The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib...

International Journal of Cancer 2010 Vol. 127; Iss. 9

The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity

Julia Salih, Julia Hilpert, Theresa Placke, Frank Grünebach, Alexander Steinle, Helmut Rainer Salih, Matthias Krusch
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
127
Year:
2010
Language:
english
Pages:
10
DOI:
10.1002/ijc.25233
File:
PDF, 937 KB
english, 2010
Conversion to is in progress
Conversion to is failed